No Data
Trump wants to impose tariffs on Pharmaceuticals: Pharmaceutical companies are busy stockpiling, and the import volume in the USA surged in March.
① The volume of Pharmaceutical imports in the USA surged in March, as pharmaceutical companies stockpiled products in anticipation of potential tariffs; ② A report released by the US Department of Commerce on Tuesday showed that the total value of Pharmaceutical imports in March exceeded 50 billion USD, equivalent to 20% of the total Pharmaceutical imports for the entire year of 2024.
The Pacific Securities: The Sector's profits improved significantly in Q1, and the pharmaceutical industry is expected to see a rapid increase in concentration.
The trend of increasing concentration in the pharmaceutical industry and the strong becoming stronger is expected to continue to strengthen.
Hong Kong stocks are moving | KINTOR PHARMA-B (09939) intraday rose nearly 14%. The combination therapy for male hair loss Ib/III clinical observational trial has reached the primary research endpoint.
KINTOR PHARMA-B (09939) rose nearly 14% during the session. As of the time of writing, it has increased by 10%, priced at 1.32 HKD, with a trading volume of 6.9331 million HKD.
Kintor Pharmaceutical Reaches Primary Endpoints in Clinical Study for Alopecia Drug
KINTOR PHARMA-B (09939): The clinical observation trial results of KX-826 combined with minoxidil for the treatment of androgenetic alopecia in adult men in China are significantly better than those of minoxidil alone.
KINTOR PHARMA-B (09939) announced regarding the combination treatment of KX-826 and minoxidil for adult men in China...
KINTOR PHARMA-B: ANNUAL REPORT 2024
